PDF(450 KB)
丙酸氟替卡松气雾剂或布地奈德混悬液干预对毛细支气管炎反复喘息的疗效观察
兰伟平, 王婧, 代传林, 潘家华
中国当代儿科杂志 ›› 2016, Vol. 18 ›› Issue (4) : 316-319.
PDF(450 KB)
PDF(450 KB)
丙酸氟替卡松气雾剂或布地奈德混悬液干预对毛细支气管炎反复喘息的疗效观察
Efficacy of fluticasone propionate aerosol versus budesonide suspension in treatment of recurrent wheezing caused by bronchiolitis
目的 比较丙酸氟替卡松气雾剂(辅舒酮)和布地奈德混悬液对毛细支气管炎再发喘息的疗效观察.方法 将初发毛细支气管炎患儿214 例随机分为辅舒酮组(106 例)和布地奈德组(108 例),分别在临床症状缓解后继续给予辅舒酮或布地奈德规律吸入.另选取临床症状缓解后未规律吸入激素的毛细支气管炎患儿136 例作为对照组.随访观察1 年.评估 2 种干预治疗对患儿反复咳喘发作的影响.结果 辅舒酮组和布地奈德组在1 年内的咳喘次数以及前3 个月的咳喘复发率均明显低于对照组(P<0.05),但两个治疗组之间差异无统计学意义(P>0.05).布地奈德组在激素用量和治疗花费方面高于辅舒酮组(P<0.01).结论 毛细支气管炎患儿临床症状缓解后继续给予辅舒酮或布地奈德规律吸入可减少咳喘发作和复发.辅舒酮在治疗费用和激素用量方面优于布地奈德.
Objective To investigate the efficacy of fluticasone propionate aerosol (flixotide) versus budesonide suspension in the treatment of recurrent wheezing caused by bronchiolitis. Methods A total of 214 infants with newly diagnosed bronchiolitis were randomly divided into flixotide treatment (106 infants) and budesonide treatment groups (108 infants), and were given aerosol inhalation of flixotide or budesonide for 3 months after achieving remission of clinical symptoms. Another 136 infants with bronchiolitis who did not receive regular inhalation of corticosteroid after achieving remission of clinical symptoms were enrolled as the control group. The follow-up visits were performed for 1 year, and the effects of the two therapeutic methods on recurrent wheezing were evaluated. Results Compared with the control group, both the flixotide and budesonide treatment groups had significantly fewer times of wheezing episodes within 1 year and a significantly lower recurrence rate of wheezing within the first 3 months after regular inhalation of corticosteroid, but no significant differences were observed between the two treatment groups. The amount of corticosteroid inhaled and hospital costs in the budesonide treatment group were significantly higher than in the flixotide treatment group (P<0.01). Conclusions Continuous inhalation of flixotide or budesonide after remission of clinical symptoms in children with bronchiolitis can reduce wheezing episodes and the recurrence of wheezing, and flixotide treatment is superior to budesonide treatment in the aspects of hospital costs and the amount of corticosteroid used.
Bronchiolitis / Inhaled corticosteroid / Recurrent wheezing / Child
[1] Florin TA, Byczkowski T, Ruddy RM, et al. Variation in the management of infants hospitalized for bronchiolitis persists after the 2006 American Academy of Pediatrics bronchiolitis guidelines[J]. J Pediatr, 2014, 165(4): 786-792.
[2] Rolfsjord LB, Skjerven HO, Bakkeheim E, et al. Children hospitalised with bronchiolitis in the first year of life have a lower quality of life nine months later[J]. Acta Paediatr, 2015, 104(1): 53-58.
[3] Midulla F, Nicolai A, Ferrara M, et al. Recurrent wheezing 36 months after bronchiolitis is associated with rhinovirus infections and blood eosinophilia[J]. Acta Paeditr, 2014, 103(10): 1094-1099.
[4] 余阗, 李云, 陈敏. 毛细支气管炎患儿肺功能特点及应用吸入性糖皮质激素的疗效[J]. 实用儿科临床杂志, 2007, 22(22): 1703-1704.
[5] 江载芳, 申昆玲. 病毒性肺炎[M]//胡亚美, 江载芳. 诸福棠实用儿科学上册. 第7 版. 北京: 人民卫生出版社, 2002: 1199-1201.
[6] Wang EE, Milner RA, Navas L, et al. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections[J]. Am Rev Respir Dis, 1992, 145(1): 106-109.
[7] Global initiative for asthma. Global strategy for asthma management and prevention (2014 revision)[EB/OL].[2015-11-23]. http://www.ginasthma.com.
[8] Teeratakulpisarn J, Pientong C, Ekalaksananan T, et al. Rhinovirus infection in children hospitalized with acute bronchiolitis and its impact on subsequent wheezing or asthma: a comparison of etiologies[J]. Asian Pac J Allergy Immunol, 2014, 32(3): 226-234.
[9] Proud D. Role of rhinovirus infections in asthma[J]. Asian Pac J Allergy Immunol, 2011, 29(3): 201-208.
[10] Tantilipikorn P, Auewarakul P. Airway allergy and viral infection[J]. Asian Pac J Allergy Immunol, 2011, 29(2): 113-119.
[11] Turunen R, Koistinen A, Vuorinen T, et al. The first wheezing episode: respiratory virus etiology, atopic characteristics and illness severity.Pediatr Allergy Immunol, 2014, 25(8): 796-803.
[12] Piippo-Savolainen E, Korppi M. Wheezy babies-wheezy adults? review on long-term outcome until adulthood after early childhood wheezing[J]. ActaPaediatr, 2008, 97(1): 5-11.
[13] Backman K, Piippo-Savolainen E, Ollikainen H, et al. Irreversible airway obstruction in adulthood after bronchiolitis in infancy: Evidence from a 30-year follow-up study[J]. Respir Med, 2014, 108(1): 218-223.
[14] 刘洁明, 周也荻, 刘晓艳, 等. 雾化吸入糖皮质激素联合特布他林及异丙托溴铵治疗毛细支气管炎的疗效及预后[J]. 实用儿科临床杂志, 2008, 23(22): 1778-1779.
